SAGE Therapeutics Inc at Bank of America Healthcare Conference Transcript
Good morning. Welcome to Day 2 of the Bank of America Healthcare conference. I'm Tazeen Ahmad. I'm one of the senior SMID biotech analyst here at Bank. It's my pleasure to have our next presenting company here with us, Sage Therapeutics. Sitting with me this morning will be Alan Chris. I'll let you guys introduce yourselves, and maybe, Chris, you could give us an overview -- a quick 2-minute overview of what's been happening at Sage Therapeutics.
Sure. I'm Chris Benecchi. I'm the Chief Commercial Officer at Sage. We show the Chief Scientific Officer of Sage Therapeutics. So first of all, Tazeen, thanks for having us. It's an exciting, and it's great to be here. It's an exciting time to be a part of Sage, and we're off to an incredibly strong start in 2022.
When you take a step back and think about what we've already accomplished -- with respect to clinical development, we are planning
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |